Objective: To evaluate the possible effects of medical expulsive therapy (MET) on the health-related quality of life (HRQOL) of patients undergoing shock wave lithotripsy (SWL) for ureteric stones. Methods: Eighty patients treated with SWL for ureteric stones were included in this study. Patients were divided into 2 groups; Group 1 received medical therapy only for colic pain and Group 2 received MET in addition to medical therapy. Patients requiring DJ stenting and auxiliary measures after SWL procedure were excluded. The remaining 54 patients were further evaluated (Group 1: n = 26, Group 2: n = 28) and followed up during the 4-week period for analgesic requirement, number of renal colic attacks, emergency department (ED) visits and the HRQOL scores by using EQ-5D index and EQ-5D visual analogue scale (VAS) values. Results: During the 4-week follow-up period, cases undergoing SWL only required significantly higher amount of analgesics. In addition to the lower number of renal colic attacks and ED visits, EQ-5D index and EQ-5D VAS values also demonstrated higher mean values in patients undergoing SWL + MET. Conclusion: In addition to the increased spontaneous stone passage rates, MET following SWL for ureteral calculi could increase the HRQOL scores by lowering the number of both renal colic attacks and ED visits along with decreased analgesic need.

Keywords:
Extracorporeal shock wave lithotripsy, Health-related quality of life, Medical expulsive therapy, Ureteral stone
1.
Teichman JM: Clinical practice. Acute renal colic from ureteral calculus. N Engl J Med 2004;350:684-693.
2.
Tiselius HG: Epidemiology and medical management of stone disease. BJU Int 2003;91:758-767.
3.
Chaussy C, Brendel W, Schmiedt E: Extracorporeally induced destruction of kidney stones by shock waves. Lancet 1980;2:1265-1268.
4.
Preminger GM, Tiselius HG, Assimos DG, et al: 2007 guideline for the management of ureteral calculi. Eur Urol 2007;52:1610-1631.
5.
Li T, Gao L, Chen P, et al: Supine versus prone position during extracorporeal shockwave lithotripsy for treating distal ureteral calculi: a systematic review and meta-analysis. Urol Int 2015, Epub ahead of print.
6.
Preminger GM, Tiselius HG, Assimos DG, et al; EAU/AUA Nephrolithiasis Guideline Panel: 2007 guideline for the management of ureteral calculi. J Urol 2007;178:2418-2434.
7.
Abe T, Akakura K, Kawaguchi M, et al: Outcomes of shockwave lithotripsy for upper urinary-tract stones: a large-scale study at a single institution. J Endourol 2005;19:768-773.
8.
El-Assmy A, El-Nahas AR, Abo-Elghar ME, et al: Predictors of success after extracorporeal shock wave lithotripsy (ESWL) for renal calculi between 20-30 mm: a multivariate analysis model. ScientificWorldJournal 2006;6:2388-2395.
9.
Bensalah K, Tuncel A, Gupta A, et al: Determinants of quality of life for patients with kidney stones. J Urol 2008;179:2238-2243; discussion 2243.
10.
Arafa MA, Rabah DM: Study of quality of life and its determinants in patients after urinary stone fragmentation. Health Qual Life Outcomes 2010;8:119.
11.
Roehrborn CG: Acute relief or future prevention: is urology ready for preventive health care? Urology 2000;56(5 suppl 1):12-19.
12.
Rabah DM, Alomar M, Binsaleh S, et al: Health related quality of life in ureteral stone patients: post-ureterolithiasis. Urol Res 2011;39:385-388.
13.
Hollingsworth JM, Rogers MA, Kaufman SR, et al: Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006;368:1171-1179.
14.
Sterrett SP, Nakada SY: Medical expulsive therapy. Curr Opin Urol 2008;18:210-213.
15.
Michel MC, de la Rosette JJ: Alpha-blocker treatment of urolithiasis. Eur Urol 2006;50:213-214.
16.
Park YH, Lee HE, Park JY, et al: A prospective randomized controlled trial of the efficacy of tamsulosin after extracorporeal shock wave lithotripsy for a single proximal ureteral stone. Korean J Urol 2013;54:527-530.
17.
Pedro RN, Hinck B, Hendlin K, et al: Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J Urol 2008;179:2244-2247; discussion 2247.
18.
Lee SR, Jeon HG, Park DS, et al: Longitudinal stone diameter on coronal reconstruction of computed tomography as a predictor of ureteral stone expulsion in medical expulsive therapy. Urology 2012;80:784-789.
19.
EuroQol Group: EQ-5D. http://www.euroqol.org/we (accessed May 20, 2008).
20.
Gambaro G, Reis-Santos JM, Rao N: Nephrolithiasis: why doesn't our ‘learning' progress? Eur Urol 2004;45:547-556; discussion 556.
21.
Karlsen SJ, Renkel J, Tahir AR, et al: Extracorporeal shockwave lithotripsy versus ureteroscopy for 5- to 10-mm stones in the proximal ureter: prospective effectiveness patient-preference trial. J Endourol 2007;21:28-33.
22.
Diniz DH, Blay SL, Schor N, et al: Anxiety and depression symptoms in recurrent painful renal lithiasis colic. Braz J Med Biol Res 2007;40:949-955.
23.
Penniston KL, Nakada SY: Health related quality of life differs between male and female stone formers. J Urol 2007;178:2435-2440; discussion 2440.
24.
Campschroer T, Zhu Y, Duijvesz D, et al: Alpha-blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst Rev 2014;4:CD008509.
25.
Zheng S, Liu LR, Yuan HC, et al: Tamsulosin as adjunctive treatment after shockwave lithotripsy in patients with upper urinary tract stones: a systematic review and meta-analysis. Scand J Urol Nephrol 2010;44:425-432.
26.
Zhu Y, Duijvesz D, Rovers MM, et al: Alpha-blockers to assist stone clearance after extracorporeal shock wave lithotripsy: a meta-analysis. BJU Int 2010;106:256-261.
27.
Han MC, Jeong WS, Shim BS: Additive expulsion effect of tamsulosin after shock wave lithotripsy for upper ureteral stones. Korean J Urol 2006;47:813-817.
28.
Pickard R, Starr K, MacLennan G, et al: Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet 2015;25:341-349.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.